In 1960, NORAC Inc. began producing Active Pharmaceutical Ingredients (API's). Today, with our FDA-inspected facility, NORAC Pharma provides state-of-the-art custom synthesis and separation capabilities to customers in the pharmaceutical industry. Offering services to clients in the areas of medicinal chemistry,  chemical development, cGMP synthesis, and advanced separation technology,  Norac Pharma has established itself as an innovative provider of chemistry services and made-to-order manufacturing in organic chemistry.  We have expertise in a wide range of synthetic organic chemistry including organometallic and photo-initiated reactions.

Through special relationships with the pharmaceutical industry , Norac Pharma is able to pursue the development of a range of compounds.  Norac Pharma expertise in the health sector reaches far beyond the mere supply of products and services which satisfy criteria of stability, safety, and purity. A true partnership operates between Norac Pharma  and its customers, particularly with regards to the synthesis of custom made products, the development of new synthetic sequences, and ancillary research and development.

We are critically aware of the decreasing market cycle times and are committed to providing you with fast and timely service.  Our comprehensive review of the production process ensures that all services are there when needed:  raw materials, production capabilities, analytical and regulatory support, etc.

Norac is approved by the DEA for manufacture, analysis and handling of  Schedule  I – V drugs.  Norac is registered with the FDA and has been inspected regularly by the agency, most recently in June 2003. NORAC's cGMP-certified laboratory and manufacturing facilities represent the state-of-the-art in API manufacturing.